Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016
- PMID: 31505631
- PMCID: PMC6761317
- DOI: 10.1093/cid/ciz462
Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016
Abstract
Background: Streptococcus pneumoniae is a leading cause of pneumonia and meningitis in children aged <5 years. Zimbabwe introduced 13-valent pneumococcal conjugate vaccine (PCV13) in 2012 using a 3-dose infant schedule with no booster dose or catch-up campaign. We evaluated the impact of PCV13 on pediatric pneumonia and meningitis.
Methods: We examined annual changes in the proportion of hospitalizations due to pneumonia and meningitis among children aged <5 years at Harare Central Hospital (HCH) pre-PCV13 (January 2010-June 2012) and post-PCV13 (July 2013-December 2016) using a negative binomial regression model, adjusting for seasonality. We also evaluated post-PCV13 changes in serotype distribution among children with confirmed pneumococcal meningitis at HCH and acute respiratory infection (ARI) trends using Ministry of Health outpatient data.
Results: Pneumonia hospitalizations among children aged <5 years steadily declined pre-PCV13; no significant change in annual decline was observed post-PCV13. Post-PCV13 introduction, meningitis hospitalization decreased 30% annually (95% confidence interval [CI], -42, -14) among children aged 12-59 months, and no change was observed among children aged 0-11 months. Pneumococcal meningitis caused by PCV13 serotypes decreased from 100% in 2011 to 50% in 2016. Annual severe and moderate outpatient ARI decreased by 30% (95% CI, -33, -26) and 7% (95% CI, -11, -2), respectively, post-PCV13 introduction.
Conclusions: We observed declines in pediatric meningitis hospitalizations, PCV13-type pneumococcal meningitis, and severe and moderate ARI outpatient visits post-PCV13 introduction. Low specificity of discharge codes, changes in referral patterns, and improvements in human immunodeficiency virus care may have contributed to the lack of additional declines in pneumonia hospitalizations post-PCV13 introduction.
Keywords: Zimbabwe; children; meningitis; pneumococcal vaccines; pneumonia.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures





Similar articles
-
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S66-S71. doi: 10.1093/cid/ciz457. Clin Infect Dis. 2019. PMID: 31505625 Free PMC article.
-
Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S58-S65. doi: 10.1093/cid/ciz456. Clin Infect Dis. 2019. PMID: 31505628 Free PMC article.
-
Use of administrative records to assess pneumococcal conjugate vaccine impact on pediatric meningitis and pneumonia hospitalizations in Rwanda.Vaccine. 2016 Oct 17;34(44):5321-5328. doi: 10.1016/j.vaccine.2016.08.084. Epub 2016 Sep 14. Vaccine. 2016. PMID: 27639280
-
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S253-S262. doi: 10.1093/infdis/jiz301. J Infect Dis. 2019. PMID: 31671444 Free PMC article.
-
The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.Hum Vaccin Immunother. 2016;12(2):277-84. doi: 10.1080/21645515.2015.1116654. Hum Vaccin Immunother. 2016. PMID: 26905678 Free PMC article. Review.
Cited by
-
Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana.Clin Infect Dis. 2021 Jul 15;73(2):e410-e416. doi: 10.1093/cid/ciaa919. Clin Infect Dis. 2021. PMID: 32634831 Free PMC article.
-
Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old.J Glob Health. 2023 Feb 3;13:05002. doi: 10.7189/jogh.13.05002. J Glob Health. 2023. PMID: 36734192 Free PMC article.
-
Characterization of bacterial and viral pathogens in the respiratory tract of children with HIV-associated chronic lung disease: a case-control study.BMC Infect Dis. 2024 Jun 26;24(1):637. doi: 10.1186/s12879-024-09540-5. BMC Infect Dis. 2024. PMID: 38926682 Free PMC article.
-
Nasopharyngeal carriage of Streptococcus pneumoniae among children and their household members in southern Mozambique five years after PCV10 introduction.Vaccine. 2025 Feb 15;47:126691. doi: 10.1016/j.vaccine.2024.126691. Epub 2025 Jan 8. Vaccine. 2025. PMID: 39787794 Free PMC article.
References
-
- UNICEF. Under-five mortality, 2018 Available at: https://data.unicef.org/topic/child-survival/under-five-mortality/. Accessed March 2018.
-
- UNAIDS. AIDSinfo, 2019 Available at: http://aidsinfo.unaids.org/. Accessed January 2019.